<DOC>
	<DOCNO>NCT00126178</DOCNO>
	<brief_summary>This international , open label , randomize phase 3 trial patient surgically removable kidney cancer randomly select post-operatively receive adjuvant treatment autologous HSPPC-96 adjuvant treatment . All patient undergo complete surgical removal tumor .</brief_summary>
	<brief_title>Clinical Trial Studying Personalized Cancer Vaccine Patients With Non-metastatic Kidney Cancer</brief_title>
	<detailed_description>This international , open label , randomize Phase 3 trial patient surgically removable kidney cancer randomly select post-operatively receive adjuvant treatment HSPPC-96 adjuvant treatment . All patient undergo complete surgical removal tumor . The primary objective study determine whether patient receive adjuvant autologous HSPPC-96 ( treatment group ) surgical resection locally advance renal cell carcinoma improve recurrence-free survival compare patient receive adjuvant treatment ( observation group ) . Eligible patient 50 % chance receive adjuvant treatment HSPPC-96 . Patients treatment arm trial receive vaccine week 4 week , every week vaccine depletion disease recurrence . Both group patient follow regularly assessment disease status . HSPPC-96 investigational , immunotherapeutic agent make individual patient 's tumor , collect time surgery . A portion tumor tissue send Antigenics ' manufacturing facility undergo process create vaccine .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>This represent full set inclusion/exclusion criterion Patients must primaryintact resectable renal cell cancer , without distant metastasis schedule surgery curative intent Tumor size &gt; 5 cm OR macroscopic node OR vena cava thrombus radiologic evaluation At least 18 year old Signed informed consent Prior surgery , chemo , hormonal , immuno , radiotherapy kidney cancer History cancer within last five year , exception adequately treat conebiopsied situ carcinoma cervix uterus , basal squamous cell carcinoma skin Current malignancy type sit No active uncontrolled infection , serious medical illness , splenectomy History primary secondary immunodeficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Kidney Cancer</keyword>
	<keyword>Renal</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Vaccine</keyword>
</DOC>